Logo

PreventionGenetics Comprehensive Miscarriage, Stillbirth, and Neonatal Death Panel

Dec 14, 2016

PreventionGenetics has launched the Comprehensive Miscarriage, Stillbirth, and Neonatal Death panel. The panel includes chromosomal microarray (CMA-ISCA) followed by a 40-gene next-generation sequencing panel in cases with a normal microarray result, or a 40-gene panel of single-gene disorders in cases with negative CMA results. If CMA has already been performed, the company said it offers the NGS panel individually.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.